{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-10-10T12:23:18.104634+00:00",
  "news": [
    {
      "title": "David Reese bets his career on the 'hinge moment' for AI at Amgen - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMie0FVX3lxTE43ZXdwcS1saXMzZjBvX1pxdkYtdG1JaVRXck94Nm5WZzlldkNtLV9VS21zQU1nN1JBTDJ2SUFWQ1prT1RjWi1xNl91YjM5Y0tUWDBsMEhwSmxVd1RUcEF1MWY2XzROSDk4WmpqT2owRmFOenpBZE1XX0ozTQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMie0FVX3lxTE43ZXdwcS1saXMzZjBvX1pxdkYtdG1JaVRXck94Nm5WZzlldkNtLV9VS21zQU1nN1JBTDJ2SUFWQ1prT1RjWi1xNl91YjM5Y0tUWDBsMEhwSmxVd1RUcEF1MWY2XzROSDk4WmpqT2owRmFOenpBZE1XX0ozTQ?oc=5\" target=\"_blank\">David Reese bets his career on the 'hinge moment' for AI at Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2025-10-08T14:00:00+00:00",
      "source": "Endpoints News"
    },
    {
      "title": "Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers - CNBC",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPWkRpS1ROdl9hMEp5dl9hTm9HaEJBR1NEdFJXNmpVbHNjaUUyeExYdDRodVJkREl5Q3ItdWM1aTQyby1tb0VrQjIxUmpFMEx3Z3RoaTkwTkNIcTQ1QU5LVXNHbmtfYWQyWjZ2VEFpNlBYdmJsVk16R0tDY3lKR2lmTl94V0NBVGF4ejdzZ2ZPbVdDVzNWaldyMXhoY9IBoAFBVV95cUxQUnozRC1oUHNMRUt5NnRpUl9xLXplTC10bjVpYmJucHd4WGRUZEVSRUQ0UG5BZnEteWNjNEVJR3R5VnpHRUJycVZGamZFV2wtNnM2UTFKSGt3dk5ROGNpeklQN2U4LTBYNUVyYl9SZzZTSFcyMWluaFdHZWszRjJiYzZqOUVSbWVxNTRRLU5lay1uNmJPNU1BSXZ0dDJzVEhI?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPWkRpS1ROdl9hMEp5dl9hTm9HaEJBR1NEdFJXNmpVbHNjaUUyeExYdDRodVJkREl5Q3ItdWM1aTQyby1tb0VrQjIxUmpFMEx3Z3RoaTkwTkNIcTQ1QU5LVXNHbmtfYWQyWjZ2VEFpNlBYdmJsVk16R0tDY3lKR2lmTl94V0NBVGF4ejdzZ2ZPbVdDVzNWaldyMXhoY9IBoAFBVV95cUxQUnozRC1oUHNMRUt5NnRpUl9xLXplTC10bjVpYmJucHd4WGRUZEVSRUQ0UG5BZnEteWNjNEVJR3R5VnpHRUJycVZGamZFV2wtNnM2UTFKSGt3dk5ROGNpeklQN2U4LTBYNUVyYl9SZzZTSFcyMWluaFdHZWszRjJiYzZqOUVSbWVxNTRRLU5lay1uNmJPNU1BSXZ0dDJzVEhI?oc=5\" target=\"_blank\">Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2025-10-07T19:31:48+00:00",
      "source": "CNBC"
    },
    {
      "title": "Pharmalittle: We're reading about Novo Nordisk layoffs, an Amgen discount program, and more - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQRTZXaGFYWGxzWmFFbm03UFZlOG8zQkt3anpEWE11VXYtN25BLU42bkFlcFNyQXpNanFmbG5XejctSmpUNFNBR2dMZElENGZ4c1puU1VMZFpad3ZqemJzRlVHMl9UMGlLdDYzUTYxZlZRelJjZlRlU2NDQWRITlVadVZNbnpfTURpaGNUenhMU1lZeHNnbjI3d0VTNkJERjlNQVFvRW40S184VHhieWVxSVk5QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiswFBVV95cUxQRTZXaGFYWGxzWmFFbm03UFZlOG8zQkt3anpEWE11VXYtN25BLU42bkFlcFNyQXpNanFmbG5XejctSmpUNFNBR2dMZElENGZ4c1puU1VMZFpad3ZqemJzRlVHMl9UMGlLdDYzUTYxZlZRelJjZlRlU2NDQWRITlVadVZNbnpfTURpaGNUenhMU1lZeHNnbjI3d0VTNkJERjlNQVFvRW40S184VHhieWVxSVk5QQ?oc=5\" target=\"_blank\">Pharmalittle: We're reading about Novo Nordisk layoffs, an Amgen discount program, and more</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-10-07T13:08:42+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60% - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxOMW9sb0NnZWRudHdDc2ZNQ3ZsOXlKRmltQlpLRUVhMkJEQkZGc1ZCQUFjUGFtZUpoUXJzRDdxaXRyUFBTd1NZSUhrSGNoNFFFQTdyZWZaM2VuOWl3T2pXV2VucjRtUHdWcHdtS2xsQTlzWUlYSFEyVDNPVU41Z0NHRWt3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxOMW9sb0NnZWRudHdDc2ZNQ3ZsOXlKRmltQlpLRUVhMkJEQkZGc1ZCQUFjUGFtZUpoUXJzRDdxaXRyUFBTd1NZSUhrSGNoNFFFQTdyZWZaM2VuOWl3T2pXV2VucjRtUHdWcHdtS2xsQTlzWUlYSFEyVDNPVU41Z0NHRWt3?oc=5\" target=\"_blank\">Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60%</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-07T17:45:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Here's What to Expect From Amgen’s Next Earnings Report - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPOU5wVndTSVZsbTk1Vmszc2I2TW9BYnlLVVIxc2hoMzdiMW9TOHlNNHFjMUVHME1NUHhTU1FXcmZTLXhxN0d1NmxISjNTdkxVUV83LVh6bDZ1UkZ0RjA5LTJaNXFwNXB5S1FxSUFPVENuWThpZWs4eGNVMzJoaDFPNmVPMGE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxPOU5wVndTSVZsbTk1Vmszc2I2TW9BYnlLVVIxc2hoMzdiMW9TOHlNNHFjMUVHME1NUHhTU1FXcmZTLXhxN0d1NmxISjNTdkxVUV83LVh6bDZ1UkZ0RjA5LTJaNXFwNXB5S1FxSUFPVENuWThpZWs4eGNVMzJoaDFPNmVPMGE?oc=5\" target=\"_blank\">Here's What to Expect From Amgen’s Next Earnings Report</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-10T08:41:26+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Colorado drug board sets first state pricing limit for Amgen’s Enbrel in 2027 - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQcUFUX0xJV0hoS2U2MXE2UWVJZGN6REk4WmVERFAwZ0NUbWszNi1XRHdLbzFoZmo5R0x1SkpyZTZMMEY2S01zVEJHb3NsSTJzY242cGFJSmJHUGtLOTIxOXRTOWdtQnlhWENsMHkzM0JxSWNmNUZRUlluLTVYMEJ6Y1pNZjUtU0E2U3Y1c3pKZ0ktNlhNVTc4d2M4WkJIUlRla0E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxQcUFUX0xJV0hoS2U2MXE2UWVJZGN6REk4WmVERFAwZ0NUbWszNi1XRHdLbzFoZmo5R0x1SkpyZTZMMEY2S01zVEJHb3NsSTJzY242cGFJSmJHUGtLOTIxOXRTOWdtQnlhWENsMHkzM0JxSWNmNUZRUlluLTVYMEJ6Y1pNZjUtU0E2U3Y1c3pKZ0ktNlhNVTc4d2M4WkJIUlRla0E?oc=5\" target=\"_blank\">Colorado drug board sets first state pricing limit for Amgen’s Enbrel in 2027</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2025-10-08T17:41:00+00:00",
      "source": "Endpoints News"
    },
    {
      "title": "AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOVC03UXRKQ3Q4OTFzYjh5bUV6WWRRRHVOU2pqcDY1MGhUbm1PQnZCTEpQYzZhcFlsN2pDSHZTU0xib0JuVVhuTlBMMVVuRGhtX1F0clBxVHM2Z2lUR1VRSkItM3VvVGh6R0NPMWhaTkRZRGVOVlFhNzdGUkZ5UWpzRk4zU2xIdkdRMkFrRl83UjB2LXFjMWdRUXh1aUs3WG94SXI5NWJqVVEyYzFSZVY5TERfZGlJOC1DbVM4RnNBbFJOVW9GbW9PQ1NydXBsdHdtTkE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOVC03UXRKQ3Q4OTFzYjh5bUV6WWRRRHVOU2pqcDY1MGhUbm1PQnZCTEpQYzZhcFlsN2pDSHZTU0xib0JuVVhuTlBMMVVuRGhtX1F0clBxVHM2Z2lUR1VRSkItM3VvVGh6R0NPMWhaTkRZRGVOVlFhNzdGUkZ5UWpzRk4zU2xIdkdRMkFrRl83UjB2LXFjMWdRUXh1aUs3WG94SXI5NWJqVVEyYzFSZVY5TERfZGlJOC1DbVM4RnNBbFJOVW9GbW9PQ1NydXBsdHdtTkE?oc=5\" target=\"_blank\">AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-09-26T07:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms - The American Journal of Managed Care® (AJMC®)",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNOWJqUGtjRG9IVGhVOVE1SFgtS0hYQlRab1pxTHJWbTNScFlRQkRoRUNqdF96bEs1RmZURFlNVWg2MElWS2JGUHlzd2N6NFozeE8yQlZFVElhZ21UOEJKdW9EazRnanBud3JqUlAzV3A0RVM1TjlNNVQ4X1lFMnBTRnpCQlBpRTBMMElySk1mUXlRd2RrN3NCYV9zazV4c2pYUW94N0VpSE1tcTByc01SVmNYUDNBLVY0YV9yb3ZFYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNOWJqUGtjRG9IVGhVOVE1SFgtS0hYQlRab1pxTHJWbTNScFlRQkRoRUNqdF96bEs1RmZURFlNVWg2MElWS2JGUHlzd2N6NFozeE8yQlZFVElhZ21UOEJKdW9EazRnanBud3JqUlAzV3A0RVM1TjlNNVQ4X1lFMnBTRnpCQlBpRTBMMElySk1mUXlRd2RrN3NCYV9zazV4c2pYUW94N0VpSE1tcTByc01SVmNYUDNBLVY0YV9yb3ZFYw?oc=5\" target=\"_blank\">Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The American Journal of Managed Care® (AJMC®)</font>",
      "published": "2025-10-06T21:09:24+00:00",
      "source": "The American Journal of Managed Care® (AJMC®)"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility - geneonline.com",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5\" target=\"_blank\">Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">geneonline.com</font>",
      "published": "2025-10-08T21:06:00+00:00",
      "source": "geneonline.com"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    },
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-10-09",
      "close": 295.42999267578125
    },
    "history": [
      {
        "date": "2025-10-01",
        "close": 298.5
      },
      {
        "date": "2025-10-02",
        "close": 297.3999938964844
      },
      {
        "date": "2025-10-03",
        "close": 297.8900146484375
      },
      {
        "date": "2025-10-06",
        "close": 294.1199951171875
      },
      {
        "date": "2025-10-07",
        "close": 295.5400085449219
      },
      {
        "date": "2025-10-08",
        "close": 294.6199951171875
      },
      {
        "date": "2025-10-09",
        "close": 295.42999267578125
      }
    ],
    "name": "Amgen Inc."
  }
}